[Report of the Bone, Joint, and Soft Tissue Pathology Working Group : DGP Conference on 4 June 2020]
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Organoid development and applications in gynecological cancers: the new stage of tumor treatment.
Li Y, Qin M, Liu N, Zhang C J Nanobiotechnology. 2025; 23(1):20.
PMID: 39819668 PMC: 11740664. DOI: 10.1186/s12951-024-03086-z.
References
1.
Bruderlein S, Sommer J, Meltzer P, Li S, Osada T, Ng D
. Molecular characterization of putative chordoma cell lines. Sarcoma. 2011; 2010:630129.
PMC: 3022207.
DOI: 10.1155/2010/630129.
View
2.
Scheipl S, Barnard M, Cottone L, Jorgensen M, Drewry D, Zuercher W
. EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen. J Pathol. 2016; 239(3):320-34.
PMC: 4922416.
DOI: 10.1002/path.4729.
View
3.
de Alava E, Gerald W
. Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 2000; 18(1):204-13.
DOI: 10.1200/JCO.2000.18.1.204.
View
4.
Renzi S, Anderson N, Light N, Gupta A
. Ewing-like sarcoma: An emerging family of round cell sarcomas. J Cell Physiol. 2018; 234(6):7999-8007.
DOI: 10.1002/jcp.27558.
View
5.
Wang L
. Identification of cancer gene fusions based on advanced analysis of the human genome or transcriptome. Front Med. 2013; 7(3):280-9.
DOI: 10.1007/s11684-013-0265-3.
View